Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce […]
Zydus Cadila has received final USFDA approval to market candesartan cilexetil tablets used for treatment of hypertension. The company will market the drug in the […]
Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now have a total of 69 […]
Cadila Healthcare has received final USFDA approval to market blood pressure drug, Tiadylt ER. The drug diltiazem hydrochloride (Tiadylt ER) extended release capsules will be […]
Zydus Cadila has received final USFDA approval to market Pindolol tablets in USA, which is used for treatment of hypertension. The company will market the […]
Zydus Cadila has received final USFDA approval to market Telmisartan and Hydrochlorothiazide tablets used in the treatment of hypertension. The company will market the drug […]
Zydus Cadila has received the final USFDA approval to market Temozolomide capsules in USA. The drug will be available in strengths of 5 mg, 20 […]
Glenmark Pharmaceuticals has received final USFDA approval for Acyclovir Ointment used for treatment of herpes virus. The drug will be made available in USP, 5 […]
Wockhardt has received final USFDA approval for its generic Oxacillin injection used for the treatment of bacterial infections. The drug will be made available in […]
Glenmark Pharmaceuticals has received final USFDA approval for generic version of Desonide cream, used to treat a variety of skin conditions. The Desonide Cream, 0.05 […]
Copyright © 2024 | WordPress Theme by MH Themes